J1414 HCPCS Level II Code: Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
Medicare Coverage & Payment
- CMS short descriptor: Inj, beqvez, per tx dose
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2025
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Contextual Map
Every relationship of J1414 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (35)
- J1410 — Injection, estrogen conjugated, per 25 mg[Sibling]— CMS HCPCS Level II code set
- J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose[Sibling]— CMS HCPCS Level II code set
- J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes[Sibling]— CMS HCPCS Level II code set
- J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose[Sibling]— CMS HCPCS Level II code set
- J1426 — Injection, casimersen, 10 mg[Sibling]— CMS HCPCS Level II code set
- J1427 — Injection, viltolarsen, 10 mg[Sibling]— CMS HCPCS Level II code set
- J1428 — Injection, eteplirsen, 10 mg[Sibling]— CMS HCPCS Level II code set
- J1429 — Injection, golodirsen, 10 mg[Sibling]— CMS HCPCS Level II code set
- and 27 more
Change history
- January 1, 2025 — Added to the code set [Change history]— CMS release files (code change ledger)
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, descriptors, coverage and pricing attributes Official source data
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Change history
- January 1, 2025Added to the code setInjection, fidanacogene elaparvovec-dzkt, per therapeutic dose
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J1414 in its code family, with their registry titles.
- J1410 — Injection, estrogen conjugated, per 25 mg
- J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
- J1426 — Injection, casimersen, 10 mg
- J1427 — Injection, viltolarsen, 10 mg
- J1428 — Injection, eteplirsen, 10 mg
- J1429 — Injection, golodirsen, 10 mg
- J1430 — Injection, ethanolamine oleate, 100 mg
- J1434 — Injection, fosaprepitant (focinvez), 1 mg